Biocept Balance Sheet Health
Financial Health criteria checks 2/6
Biocept has a total shareholder equity of $290.0K and total debt of $526.0K, which brings its debt-to-equity ratio to 181.4%. Its total assets and total liabilities are $22.1M and $21.8M respectively.
Key information
181.4%
Debt to equity ratio
US$526.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.63m |
| Equity | US$290.00k |
| Total liabilities | US$21.81m |
| Total assets | US$22.10m |
Recent financial health updates
Recent updates
Biocept, Inc. (NASDAQ:BIOC) Shares Fly 48% But Investors Aren't Buying For Growth
Apr 17
Statutory Earnings May Not Be The Best Way To Understand Biocept's (NASDAQ:BIOC) True Position
Nov 23Just In: One Analyst Has Become A Lot More Bullish On Biocept, Inc.'s (NASDAQ:BIOC) Earnings
Aug 19Shareholders Will Probably Hold Off On Increasing Biocept, Inc.'s (NASDAQ:BIOC) CEO Compensation For The Time Being
Jul 03Biocept and CLEARED4 ink collaboration agreement
Jun 09Biocept enters COVID-19 testing partnership
Apr 28Biocept (NASDAQ:BIOC) Shareholders Have Enjoyed An Impressive 104% Share Price Gain
Mar 13We're Keeping An Eye On Biocept's (NASDAQ:BIOC) Cash Burn Rate
Jan 26
Biocept, Inc. (NASDAQ:BIOC): Is Breakeven Near?
Dec 22Biocept's assays viable and sensitive for detecting tumor cells and biomarkers
Nov 20Biocept +4% on COVID-19 testing update
Nov 12Financial Position Analysis
Short Term Liabilities: BIOC's short term assets ($8.9M) exceed its short term liabilities ($4.9M).
Long Term Liabilities: BIOC's short term assets ($8.9M) do not cover its long term liabilities ($16.9M).
Debt to Equity History and Analysis
Debt Level: BIOC has more cash than its total debt.
Reducing Debt: BIOC's debt to equity ratio has increased from 20% to 181.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BIOC has less than a year of cash runway if free cash flow continues to grow at historical rates of 15.3% each year.